Document Detail


Patients who have dilated cardiomyopathy must have a trial of bridge to recovery: the case against that proposition.
MedLine Citation:
PMID:  17723939     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The idea that patients who have dilated cardiomyopathy (presumably a large heart with near-normal coronary arteries) must have a trial of bridge to recovery is risible. Many such patients should be managed so that they go directly to transplantation and others may be better treated with drug therapy. Some may be more suited to destination therapy. What is needed in this field is more precise terminology, clearer statements of clinical intent at the time of device insertion, improved characterization of patients, more accurate clinical assessment, and above all more information from randomized clinical trials.
Authors:
Philip A Poole-Wilson
Related Documents :
19815379 - Diastolic dysfunction and its histopathological correlation in obstructive hypertrophic...
20854969 - Abnormalities of cardiac repolarization in williams syndrome.
20171599 - Resistin gene promoter region polymorphism and the risk of hypertrophic cardiomyopathy ...
1977849 - Apical hypertrophic cardiomyopathy: clinical, echocardiographic and angiographic featur...
19375919 - Idiopathic hypertrophic cranial pachymeningitis and dural sinus occlusion: two patients...
7193039 - Assessment of chest pain in hypertrophic cardiomyopathy using exercise thallium-201 myo...
8422739 - A predictor for side effects in patients with alzheimer's disease treated with deferoxa...
21033259 - Incidence of pancreatic carcinoma in patients with chronic pancreatitis.
20373079 - Outcome of patients with primary hepatic venous obstruction treated with anticoagulants...
Publication Detail:
Type:  Comment; Journal Article; Review    
Journal Detail:
Title:  Heart failure clinics     Volume:  3     ISSN:  1551-7136     ISO Abbreviation:  -     Publication Date:  2007 Jul 
Date Detail:
Created Date:  2007-08-28     Completed Date:  2007-09-28     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  101231934     Medline TA:  Heart Fail Clin     Country:  United States    
Other Details:
Languages:  eng     Pagination:  317-9     Citation Subset:  IM    
Affiliation:
National Heart & Lung Institute, Imperial College London, London, UK. p.poole-wilson@imperial.ac.uk <p.poole-wilson@imperial.ac.uk>
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Biological Markers / analysis
Blood Flow Velocity
Cardiomyopathy, Dilated / physiopathology,  surgery*
Heart Function Tests
Heart Transplantation
Heart-Assist Devices / contraindications*
Humans
Patient Selection
Randomized Controlled Trials as Topic
Recurrence
Survival Rate
Ventricular Dysfunction, Left / physiopathology,  surgery*
Chemical
Reg. No./Substance:
0/Biological Markers
Comments/Corrections
Comment On:
Heart Fail Clin. 2007 Jul;3(3):299-315   [PMID:  17723938 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Patients who have dilated cardiomyopathy must have a trial of bridge to recovery (pro).
Next Document:  Cardiac transplantation: any role left?